Electrocoagulation vs. Cold Knife Cutting in Joint Arthroplasty (Electrocoagulation vs Scalpel)
Launched by IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY · Feb 1, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different surgical techniques used during joint replacement surgeries, specifically for total hip and knee replacements. One technique uses electrocoagulation, a method that uses heat to control bleeding, while the other uses a traditional cold knife, or scalpel, to make cuts. The goal is to find out which method leads to better recovery and overall results for patients undergoing these surgeries.
To participate in this study, you need to be at least 18 years old and have certain joint problems that require surgery, like severe arthritis or fractures. You'll also need to be able to understand and agree to the procedure. If you have serious health issues that could complicate surgery or are dealing with ongoing infections, you may not be eligible. Participants can expect regular follow-ups after their surgery to monitor their recovery and help researchers understand the outcomes of each technique. This trial is currently looking for volunteers, and everyone's health and safety are a top priority throughout the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who have given informed consent to the procedure
- • Patients admitted over 18 years of age
- • Patients with pathology requiring primary joint replacement (symptomatic gonarthrosis/coxarthrosis, Avascular necrosis (AVN) of the femoral head , femoral neck fractures, etc)
- Exclusion Criteria:
- • Contraindications for major surgery or anaesthesia
- • Patients with active infections that could interfere with outcome assessment
- • Patients unable to give informed consent for psychological or cognitive reasons
- • Severe medical conditions such as coagulopathies that may significantly influence outcomes
- • Patients unable or unwilling to adhere to the required follow-up period
- • Patients who died during the study period
- • Patients with revision prosthesis operations
About Iuliu Hatieganu University Of Medicine And Pharmacy
Iuliu Hatieganu University of Medicine and Pharmacy is a prestigious academic institution located in Cluj-Napoca, Romania, renowned for its commitment to advancing medical education and research. As a clinical trial sponsor, the university leverages its extensive expertise in medical sciences and collaborative networks to facilitate innovative research initiatives aimed at improving healthcare outcomes. With a focus on ethical standards and regulatory compliance, the university fosters a dynamic environment for clinical investigations that contribute to the development of new therapies and enhance patient care. Its multidisciplinary approach and dedication to scientific excellence position it as a leading entity in the field of medical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cluj Napoca, Cluj, Romania
Patients applied
Trial Officials
Benea R Horea, MD
Principal Investigator
Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported